Successful clinical trial for ketamine-like antidepressant

Researchers are reporting a successful phase IIa clinical trial of GLYX-13, a first-of-its-kind ketamine-like antidepressant that takes effect within 24 hours and delivers double the antidepressant effect of traditional selective serotonin re-uptake inhibitor (SSRI) treatments. Details of the clinical development of GLYX-13 appear in the current issue of the journal Neuropsychopharmacology and the trial results were presented last Thursday at the 51st Annual Meeting of the American College of Neuropsychopharmacology.

GLYX-13 was developed by a team led by Joseph Moskal, research professor of biomedical engineering at Northwestern University. Moskal said the drug was novel because it targets the brain receptors responsible for learning and memory – a very different approach from SSRI antidepressants. The researchers speculate it also could be helpful in treating other neurological conditions, including schizophrenia, bipolar disorder, anxiety and Alzheimer’s disease.

GLYX-13 works by modulating the N-methyl-D-aspartate (NMDA) receptor in the brain, as do other NMDA receptor antagonists such as ketamine, but GLYX-13 does not have their serious and limiting side effects, such as hallucinations and schizophrenia-like effects. NMDA receptors play a key role in regulating synaptic plasticity – the quality of the connection between neurons – and thus are important in regulating learning and memory functions.

In trials administered at 12 sites across the country, a single dose of GLYX-13 resulted in significant reductions in depression symptoms among subjects who had shown little improvement with previous drugs. The positive effects of GLYX-13 were evident within 24 hours and lasted an average of seven days. The effect size, a measure of the magnitude of the drug’s antidepressant efficacy, at both these times after a single dose was nearly double the effect size seen with most other antidepressant drugs after four to six weeks of repeated dosing. Side effects of GLYX-13 were mild to moderate and were consistent with those observed in subjects receiving a placebo.

GLYX-13 is administered intravenously but Moskal is working on an oral version. The drug is currently undergoing a phase IIb clinical trial at 20 sites across the United States. This trial is evaluating repeated doses of the drug.

Related:
Discuss this article in our forum
Hygiene Hypothesis linked to depression
Depression caused by brain inflammation?
Our Love Affair With Depression
Scientists manipulate immune system to produce “anti-Prozac”

Source: Northwestern University

, ,

Comments are closed.

Ketamine ketaset bottle music festival enamel lapel hat pin picture

Ketamine ketaset bottle music festival enamel lapel hat pin

$15.00



Ketamine bottle enamel pin l/e Ketamine therapy pin by COSM man limited edition picture

Ketamine bottle enamel pin l/e Ketamine therapy pin by COSM man limited edition

$75.00



Ketamine therapy molecule enamel lapel hat pin badge b quality special k khole picture

Ketamine therapy molecule enamel lapel hat pin badge b quality special k khole

$23.00



Fear and Loathing Las Vegas Hunter S. Thompson tool hemp ketamine dmt mdma picture

Fear and Loathing Las Vegas Hunter S. Thompson tool hemp ketamine dmt mdma

$19.99



K*Bert Cuburt Drugs Adult Humor Gag Gift Stoner Vulgar Ketamine Gamer Lapel Pin picture

K*Bert Cuburt Drugs Adult Humor Gag Gift Stoner Vulgar Ketamine Gamer Lapel Pin

$9.50



KETAMINE VERSED PIRATE PATCH EMS  RSI PARAMEDIC picture

KETAMINE VERSED PIRATE PATCH EMS RSI PARAMEDIC

$6.99



Ketamine Versed Patch & Vinyl Sticker Combo EMS RSI Paramedic Anesthesia EM CRNA picture

Ketamine Versed Patch & Vinyl Sticker Combo EMS RSI Paramedic Anesthesia EM CRNA

$11.10



Ketamine Versed Patch EMS RSI Paramedic Anesthesia EM CRNA picture

Ketamine Versed Patch EMS RSI Paramedic Anesthesia EM CRNA

$6.00



Rocuronium Ketamine Dunkin Patch EMS RSI Paramedic Anesthesia EM CRNA picture

Rocuronium Ketamine Dunkin Patch EMS RSI Paramedic Anesthesia EM CRNA

$6.00



Special K Hello Cartoon Cat Ketamine Glow in the dark Enamel Lapel Hat Pin  picture

Special K Hello Cartoon Cat Ketamine Glow in the dark Enamel Lapel Hat Pin

$9.99



Powered by WordPress. Designed by WooThemes